Eli Lilly, Astellas Venture Management, Wilson Sonsini Goodrich & Rosati and Zambon subsidiary Zcube all contributed to the firm's $60m third fund.

Mission Bay Capital, the venture capital arm of University of California-aligned commercialisation office California Institute for Quantitative Biosciences (QB3), has raised $60m for its latest fund from limited partners including several corporates. Pharmaceutical firms Eli Lilly and Astellas contributed, the latter through its Astellas Venture Management unit, as did law firm Wilson Sonsini Goodrich &…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.